Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Abisch

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Experientia|January 1, 1970
[Deacetylation of cardenolides with the zinc acetate method]E Abisch, J Binkert
European Journal of Clinical Pharmacology|January 1, 1983
The pharmacokinetics of subcutaneous dihydroergotamine with and without a dextran 70 infusionB Lindblad, E Abisch, D Bergqvist
Clinical Chemistry|October 1, 1983
Temperature dependency of apparent cyclosporin A concentrations in plasmaM Wenk, F Follath, E Abisch
European Journal of Clinical Pharmacology|January 1, 1986
Pharmacokinetics of oral cyclosporin A (Sandimmun) in healthy subjectsJ Grevel, E Nüesch, E Abisch, et al.
European Journal of Clinical Pharmacology|January 1, 1984
Steady state bioavailability of a new oral formulation of Hydergine in geriatric patientsF Sörgel, E Abisch, H J Dennler, et al.
European Journal of Clinical Pharmacology|January 1, 1988
Differential effect of food on kinetics of bromocriptine in a modified release capsule and a conventional formulationJ Drewe, N Mazer, E Abisch, et al.
Progress in Allergy|January 1, 1986
Cyclosporin. Bioanalytical considerationsH F Schran, W T Robinson, E Abisch, et al.
Journal of Immunoassay|January 1, 1981
A radioimmunoassay to measure cyclosporin A in plasma and serum samplesP Donatsch, E Abisch, M Homberger, et al.
Clinical Chemistry|February 1, 1988
Specific 3H radioimmunoassay with a monoclonal antibody for monitoring cyclosporine in bloodP E Ball, H Munzer, H P Keller, et al.
European Journal of Clinical Pharmacology|January 1, 1988
The absolute systemic availability of a new oral formulation of co-dergocrine in healthy subjectsP Dominiak, J Grevel, E Abisch, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Experientia|January 1, 1970
[Deacetylation of cardenolides with the zinc acetate method]E Abisch, J Binkert
European Journal of Clinical Pharmacology|January 1, 1983
The pharmacokinetics of subcutaneous dihydroergotamine with and without a dextran 70 infusionB Lindblad, E Abisch, D Bergqvist
Clinical Chemistry|October 1, 1983
Temperature dependency of apparent cyclosporin A concentrations in plasmaM Wenk, F Follath, E Abisch
European Journal of Clinical Pharmacology|January 1, 1986
Pharmacokinetics of oral cyclosporin A (Sandimmun) in healthy subjectsJ Grevel, E Nüesch, E Abisch, et al.
European Journal of Clinical Pharmacology|January 1, 1984
Steady state bioavailability of a new oral formulation of Hydergine in geriatric patientsF Sörgel, E Abisch, H J Dennler, et al.
European Journal of Clinical Pharmacology|January 1, 1988
Differential effect of food on kinetics of bromocriptine in a modified release capsule and a conventional formulationJ Drewe, N Mazer, E Abisch, et al.
Progress in Allergy|January 1, 1986
Cyclosporin. Bioanalytical considerationsH F Schran, W T Robinson, E Abisch, et al.
Journal of Immunoassay|January 1, 1981
A radioimmunoassay to measure cyclosporin A in plasma and serum samplesP Donatsch, E Abisch, M Homberger, et al.
Clinical Chemistry|February 1, 1988
Specific 3H radioimmunoassay with a monoclonal antibody for monitoring cyclosporine in bloodP E Ball, H Munzer, H P Keller, et al.
European Journal of Clinical Pharmacology|January 1, 1988
The absolute systemic availability of a new oral formulation of co-dergocrine in healthy subjectsP Dominiak, J Grevel, E Abisch, et al.
Pageof 2